F

irst cancer. Now, Parkinson’s?

The idea that one disease is actually several, each driven by its own genetics and differing in everything from age of onset to response to drugs, made cancer the poster child for precision medicine. Now, a $4 million study announced on Monday aims to see whether a genetically informed precision-medicine approach might work for Parkinson’s, too.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Reply to John A Mazurek Cancel reply

Please enter your name.
Please enter a comment.

  • Cancel my subscription. Your site is impossible to work with:
    1. You never remember my password and constantly need it resubmitted
    2. When I click “forgot your password” there is no response
    3.STAT is not a convenient site to work with

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.